Related Experiment Video
Updated: Jun 2, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
"It Will Make It Easier for Us to Live Better": Perspectives on Long-Acting Injectable HIV Treatment Among
Manami Diaz Tsuzuki1, Rey Flores2, Xavier A Erguera3,4
1School of Medicine, University of California San Francisco, San Francisco, California.
Abstract:
Long-acting injectable ART (LAI-ART) may mitigate barriers to ART adherence, but research is needed to optimize LAI-ART for Spanish-speaking people with HIV (PWH). As part of a larger multi-site qualitative study, we conducted 20 semistructured interviews with monolingual Spanish-speaking PWH at a Ryan White-funded academic HIV clinic. Transcripts were analyzed in Spanish using thematic analysis. The median age of participants was 47 years (range 25-68), 30% were cis women, 10% were trans women, and all were born in Latin America. Three themes emerged: (1) injection familiarity as a mediator of LAI-ART acceptability, (2) concerns about the compatibility of LAI-ART with one's body, and (3) concerns that use of LAI-ART could impact the ability to return to one's country of origin. Monolingual Spanish-speaking PWH demonstrated substantial interest in LAI-ART. Provider awareness of patients' preferences, beliefs, and migration considerations can help empower patients to make informed decisions about their HIV care.
Related Concept Videos
Retrovirus Life Cycles
Health Literacy
Drug Therapy
Antianxiety Medications
Amebiasis
Therapeutic Drug Monitoring: Affecting Factors
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

